Clinical Trial Update: REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial by Recordati Group evaluating investigational eye drops for moderate to severe Neurotrophic keratitis in adults has completed, with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotrophic Keratitis

Drugs mentioned

• Investigational eye drops (neurotrophic keratitis)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Neurotrophic Keratitis | Phase 2 | Status: COMPLETED | Results posted: 2025-05-14